Novel ALK ‐ EML4 fusion in a gastric gastrointestinal stromal tumour: towards emerging therapeutic options
Histopathology · 2026-12 · 89 (6) · 1105-1107
DOI: 10.1111/his.70299 ↗Kurz gefasst
Leserbrief in der Zeitschrift Histopathology, online erschienen am 08.10.2026. Verfasst von Begoña O Alén und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, A Coruña, Spain. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pathology Department, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, A Coruña, Spain.
ORCID-Profile: Begoña O Alén, Begoña Sanromán-Budiño, Jorge Pombo-Otero, Ángel Concha
Zitieren
APA
Alén, B. O., Sanromán-Budiño, B., Rodríguez-López, A., Pombo-Otero, J., & Concha, Á. (2026). Novel ALK ‐ EML4 fusion in a gastric gastrointestinal stromal tumour: towards emerging therapeutic options. Histopathology, 89(6), 1105-1107. https://doi.org/10.1111/his.70299
Vancouver
Alén BO, Sanromán-Budiño B, Rodríguez-López A, Pombo-Otero J, Concha Á. Novel ALK ‐ EML4 fusion in a gastric gastrointestinal stromal tumour: towards emerging therapeutic options. Histopathology. 2026;89(6):1105-1107. doi:10.1111/his.70299
BibTeX
@article{Aln2026,
author = {Alén, Begoña O and Sanromán-Budiño, Begoña and Rodríguez-López, Antía and Pombo-Otero, Jorge and Concha, Ángel},
title = {Novel ALK ‐ EML4 fusion in a gastric gastrointestinal stromal tumour: towards emerging therapeutic options},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {6},
pages = {1105--1107},
doi = {10.1111/his.70299}
}
EUVIMED